TScan Therapeutics Reveals Key Presentations for SITC Annual Meeting
TScan Therapeutics to Participate in SCTC Annual Meeting
TScan Therapeutics, Inc. (Nasdaq: TCRX), a pioneering biotechnology firm, is set to share breakthrough advancements at an upcoming major event. With a dedicated focus on developing T cell receptor-engineered T cell (TCR-T) therapies aimed at tackling various cancers, TScan will display its latest research findings.
Details of the Poster Presentations
Discovering MAGE-A4-specific TCR-T Therapy
The first poster will highlight a significant discovery: a MAGE-A4-specific TCR-T therapy candidate specifically designed for multiplex treatment of solid tumors. This innovative approach is the result of collaborative efforts from esteemed authors such as Rutuja Kulkarni and Akshat Sharma, along with many others. This presentation is scheduled for November 8 from 9:00 a.m. to 7:00 p.m. Central Time at the George R. Brown Convention Center.
Preclinical Models for T-Plex Therapy
Another compelling presentation will delve into preclinical models for T-Plex, a customized multiplexed TCR-T cell therapy that addresses the complexities of intra-tumor antigen and HLA heterogeneity. Led by researchers like Maytal Bowman, this work underscores the intricacies of cancer treatment and is essential viewing for those involved in oncology. It will also take place on November 8 during the same hours and location.
Target Agnostic Platform Development
Additionally, there will be a session focusing on the development of a target agnostic platform that evaluates the reactivity of TCR-T therapies to primary human tissues. This research involves a diverse group of contributors, including Sveta Padmanabhan and Shubhangi Kamalia, and will be presented on November 9 from 9:00 a.m. to 8:30 p.m. Central Time at the same venue. This platform has the potential to transform how TCR-T therapies are assessed before reaching patients.
About TScan Therapeutics
TScan Therapeutics specializes in innovative TCR-T therapies aimed at enhancing treatment outcomes for cancer patients. Their lead candidates, TSC-100 and TSC-101, are being developed to prevent relapse in patients undergoing allogeneic hematopoietic cell transplantation. The company is also expanding its therapeutic repertoire with various candidates targeting solid tumors.
Moreover, TScan continues to enhance its ImmunoBank, a vital collection of therapeutic TCRs. This repository targets a variety of cancer indications, creating customized multiplex TCR-T therapies tailored to individual patient needs.
Contact Information
Should you require further information or wish to discuss collaboration opportunities, please reach out to:
Heather Savelle
TScan Therapeutics, Inc.
VP, Investor Relations
857-399-9840
hsavelle@tscan.com
Maghan Meyers
Argot Partners
212-600-1902
TScan@argotpartners.com
Frequently Asked Questions
What is the main focus of TScan Therapeutics?
TScan Therapeutics focuses on developing TCR-engineered T cell therapies for cancer treatment, aiming for innovative solutions for various malignancies.
Where will the SITC Annual Meeting take place?
The 39th Annual Meeting of the Society for Immunotherapy of Cancer will occur at the George R. Brown Convention Center.
When are the poster presentations scheduled?
The poster presentations are scheduled for November 8 and November 9, with specific time slots allocated for each research topic.
Who are some of the authors involved in these presentations?
Notable authors include Rutuja Kulkarni, Maytal Bowman, and Sveta Padmanabhan, among a collaborative team of researchers.
What breakthroughs will be discussed at the meeting?
The meeting will discuss advancements in TCR-T therapies, preclinical models for multiplex treatments, and a target agnostic platform for assessing therapy effectiveness.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Fortinet Triumphs as Premier Leader in SD-WAN for 2024
- BLG International and Verona Real Estate Group Join Forces
- CEO Wesley Edens Invests $50 Million in New Fortress Energy
- Key Developments in AMMO, Inc. Class Action Lawsuit Notifications
- Oppenheimer's Positive Outlook for Barnes Group Amid Acquisition Talks
- EBSWARE Unveils Advanced Trading Platform for Diverse Assets
- Athens Market Sees Positive Gains as Key Sectors Surge
- Boeing and Lockheed's Vulcan Rocket Achieves Key Milestone
- Take Action Now: Important Update for NNE Shareholders
- Navigate Market Trends: Insights on Key Stocks for Investors
Recent Articles
- California Resources Corporation Empowers Rams' Carbon Journey
- Cloud Theory Reports Record New Vehicle Inventory Growth
- Exploring Middlefield Canadian Income's Latest Asset Value Insights
- Medicenna Unveils Innovative Data at Leading Cancer Meeting
- ODDSworks Enters Mexican iGaming Market with Novibet
- Exploring SP Group A/S Share Buy-Back Program Details
- Exciting New Development: Hard Rock Hotel Malta Underway
- Tellurian's Stockholders Approve Significant Merger Agreement
- Insights from MiNK Therapeutics' iNKT Cell Programs Presentations
- Grammarly Recognized as Leader in Generative AI Solutions
- FDA Takes Bold Action: 16 New Cancer Therapies Approved Recently
- Investigation of CrowdStrike’s Leadership for Possible Failures
- Discover Secret Strategies for Affordable Holiday Travel
- Celebrating Excellence: 2024 ISG Paragon Awards Winners Announced
- DuPont Enhances Photoresist Production Capacity in Japan Facility
- Janus Henderson's Q3 2024 Results and Investor Call Details
- Moleculin Biotech Announces Engaging Conferences for Investors
- SilverBox Corp IV Launches Trading of Class A Shares and Warrants
- Healthy.io Receives Digital Health Awards Finalist Recognition
- FBFK Law Facilitates Major Acquisition in Tech Sector
- Allergan Aesthetics Partners with Girls Inc. to Empower Future STEM Leaders
- Bitwise Asset Management Transitions ETFs With Innovative Strategies
- SS&C Technologies to Announce Q3 2024 Financial Results Soon
- Understanding Copart's P/E Ratio and Market Position
- Optomi Professional Services Welcomes New Chief Revenue Officer
- Apple Expands Retail Presence in India with New Stores
- Celebrating Excellence in Healthcare Marketing at the Gala
- Exploring Telegram's Privacy Changes: Impact on Social Media Landscape
- HotSpot Therapeutics Unveils Promising Data on HST-1011
- Newterra Enhances Water Treatment Capabilities in Southeast
- Phoenix Children's Enhances Leadership for Comprehensive Care
- Cullen/Frost Bankers, Inc. Announces Earnings Call for Q3 2024
- Russel Metals Announces Investor Conference Call Details
- New Members Appointed to Vitrolife AB's Election Committee
- Sugar Grove Ace Commemorates a Decade of Community Support
- Immuron Ltd's Promising Progress in Biopharmaceutical Research
- IREN Expands Bitcoin Mining and AI Services to New Heights
- Wells Fargo Highlights Earnings Guidance Concerns for J&J
- Nvidia Insights: Selling Spree, Predictions, and Innovations
- First Western Financial to Share Q3 2024 Results and Insights
- US Labor Market Surprises with Strong Job Growth Data
- Verizon's Upcoming Earnings Report: What Investors Should Know
- Resignation at Trump Media Signals Changes Ahead for TMTG
- Rocky Mountain Chocolate Factory Secures New $6 Million Credit
- Exciting Matchup at the 36th Canada Shrine Bowl Event
- Shipping Container Industry: Key Trends Driving Growth
- Gina Breslin Joins JBT Bancorp, Inc. Board Enhancing Leadership
- AI in Networks Market Growth: Key Insights and Forecasts
- Stellantis Issues Recall for Over 129,000 Ram 1500 Trucks
- Exploring the Bright Future of the Wagyu Beef Industry